title: Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases).
authors.affiliation: Department of Internal Medicine, Allergy, Clinical Immunology and Rheumatology Unit, University of Milan, Ospedale San Luca, Via Spagnoletto, 3, 20149, Milan, Italy.
authors.forename: Maria
authors.initials: M
authors.lastname: Gerosa
authors.forename: Cecilia
authors.initials: C
authors.lastname: Chighizola
authors.forename: Pier Luigi
authors.initials: PL
authors.lastname: Meroni
mesh_terms: D017152:Antibodies, Antiphospholipid / Q000097:blood*; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011322:Primary Prevention; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
chemical_list: D017152:Antibodies, Antiphospholipid; D005343:Fibrinolytic Agents; D001241:Aspirin